<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-vaccines-08-00197">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Herrera-Rodriguez</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Meijerhof</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Niesters</surname>
    <given-names>H.G.</given-names>
   </name>
   <name>
    <surname>Stjernholm</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Hovden</surname>
    <given-names>A.-O.</given-names>
   </name>
   <name>
    <surname>Sørensen</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ökvist</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sommerfelt</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Huckriede</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model</article-title>
  <source>Virology</source>
  <year>2018</year>
  <volume>515</volume>
  <fpage>21</fpage>
  <lpage>28</lpage>
  <pub-id pub-id-type="doi">10.1016/j.virol.2017.11.018</pub-id>
  <pub-id pub-id-type="pmid">29223787</pub-id>
 </element-citation>
</ref>
